As of January 24, 2025, NeuroPace (NPCE) has a market cap of $0.42 billion USD. According to our data, NeuroPace is ranked No.6344 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 24, 2025 | $0.42 B |
25.47%
|
Dec 31, 2024 | $0.33 B |
8.54%
|
Dec 29, 2023 | $0.31 B |
591.95%
|
Dec 30, 2022 | $44.47 M |
-85.22%
|
Dec 31, 2021 | $0.30 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Medtronic
MDT
|
$115.24 B |
0.002 M
|
Ireland
|
Boston Scientific
BSX
|
$150.12 B |
0.005 M
|
USA
|
Abbott Laboratories
ABT
|
$216.32 B |
-0.006 M
|
USA
|
Zimmer Biomet
ZBH
|
$22.22 B |
0.000 M
|
USA
|
Stryker Corporation
SYK
|
$149.71 B |
1.910 M
|
USA
|
Edwards Lifesciences
EW
|
$40.65 B |
-0.001 M
|
USA
|
Johnson & Johnson
JNJ
|
$353.68 B |
-0.001 M
|
USA
|
Becton Dickinson
BDX
|
$70.13 B |
0.001 M
|
USA
|
Intuitive Surgical
ISRG
|
$208.90 B |
0.000 M
|
USA
|
Smith & Nephew
SNN
|
$11.07 B |
0.156 B
|
UK
|
Baxter
BAX
|
$16.25 B |
-0.000 M
|
USA
|
ResMed
RMD
|
$36.53 B |
-0.002 M
|
USA
|
Hologic
HOLX
|
$16.13 B |
0.000 M
|
USA
|
Teleflex
TFX
|
$8.36 B |
0.000 M
|
USA
|
Market Cap | = | NPCE Stock Price | * | NPCE Shares Outstanding |
= | $14.04 | * | 29.85 M | |
= | $0.42 B |